Zdrowie i gospodarka · 09/05/2025

FDA Clears VOSOL 2% Otic Solution/Drops for Continued Sale

The FDA has determined that VOSOL 2% Otic Solution/Drops and other listed drug products were not withdrawn from sale due to safety or effectiveness concerns. This decision means the FDA will not initiate withdrawal procedures and will continue to approve ANDA applications for these products as long as they meet regulatory requirements.